ZYME Zymeworks Inc. - Common Stock
$27,70
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla Ağu 6, 2026
52 Haftlık Aralık
$13–$30
87% of range
Analist Derecelendirmesi
BUY
18 analysts
Fiyat Hedefi
$40
+46% upside
P/E (TTM)
-25.6
ROE
-26.9%
Net Kâr Marjı
-76.6%
Zymeworks Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange.
Devamını oku
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver,
British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange.
In May 2019, Zymeworks announced that GSK has expanded its 2016 licensing and collaboration agreement for the research, development and commercialization of bispecific antibodies across multiple disease areas. The extended agreement has meant that GSK can have access to Zymeworks' heavy-light chain pairing technology, which enables the development of bispecific and multifunctional therapeutics.
In September 2019, Zymeworks announced that, following their clinical trials, it has been confirmed that their ZW25 monotherapy can provide durable disease control in patients with a variety of HER2-expressing solid tumors that have progressed following standard of care treatments.
In May 2022, Zymeworks rejected an unsolicited takeover proposal from a Dubai hedge fund, All Blue Falcons FZE, an arm of All Blue Capital.
Azymetric
This is an IgG1-based heterodimeric antibody scaffold that consists of two different heavy chains engineered to exclusively assemble into a single molecule, allowing bi-specific binding to two different antigens or drug targets. The Azymetric scaffold is engineered by making amino acid changes in the CH3 region of the constant Fc domain of the IgG1. This scaffold can also be engineered with tailored effector function and optimized serum half-life.
Awards and recognition
Deal of the Year, Lifesciences BC Awards, 2018
Life Sciences Company of the Year, Lifesciences BC Awards, 2016
Emerging company of the year – Health, BIOTECanada Gold Leaf Awards, 2015
12th Place, BC's Leading Innovators, 2011
Life Science Emerging Rocket, 2009, 2010, 2011
Early stage Company of the year – Industrial & Agriculture, BIOTECanada Gold Leaf Awards, 2009
== References ==
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
ZYME Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$27.70
Piyasa Değeri
$2.07B
P/E (TTM)
-25.6
EPS (TTM)
$-1.08
Gelir (TTM)
$106M
Temettü Verimi
—
ROE
-26.9%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$13 – $30
ZYME Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$106M
2020-12-31
→
2025-12-31
Hisse Başına Kâr
$-1.08
2020-12-31
→
2025-12-31
Serbest Nakit Akışı
$-35M
2023-12-31
→
2025-12-31
Marjlar
-76.6%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
ZYME
Akran Ortalaması
P/E (TTM)
-25.6
—
P/S (TTM) (F/S (TTM))
19.5
418.4
P/B (F/D)
7.7
2.3
Price / FCF (Fiyat / Serbest Nakit Akışı)
-59.9
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
ZYME
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-87.3%
—
Net Profit Margin (Net Kâr Marjı)
-76.6%
-549.8%
ROA
-20.0%
-41.8%
ROE
-26.9%
-54.1%
ROIC
-35.1%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
ZYME
Akran Ortalaması
Current Ratio (Cari Oran)
5.9
12.6
Quick Ratio (Cari Oran)
1.1
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
ZYME
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
38.9%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
-36.4%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
22.2%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
ZYME
Akran Ortalaması
ZYME Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
18 analist
- Güçlü Al 6 33,3%
- Al 11 61,1%
- Tut 1 5,6%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
12 analist · 2026-08-16
Medyan
$38.50
← Tüm hedeflerin altında
$27.70
Düşük
$31.00
Yüksek
$58.00
Medyan hedef
$38.50
+39,0%
Ortalama hedef
$40.33
+45,6%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.01%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-0.62 | $-0.50 | -0.12% |
| 31 Mart 2026 | $-0.59 | $-0.20 | -0.39% |
| 31 Aralık 2025 | $-0.55 | $-0.42 | -0.13% |
| 30 Eylül 2025 | $-0.26 | $-0.33 | 0.07% |
| 30 Haziran 2025 | $0.03 | $-0.50 | 0.53% |
| 31 Mart 2025 | $-0.30 | $-0.42 | 0.12% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | — |
| AUPH | $2.11B | 7.7 | 20.4% | 101.5% | 62.7% | — |
| ABUS | $926M | -28.3 | 128.2% | -237.9% | -42.0% | — |
| ACOG | $141M | -5.5 | — | -202.2% | -43.8% | — |
| PMN | $15M | -0.3 | — | — | 4840.3% | — |
| XENE | $3.59B | -10.3 | — | -4612.1% | -56.9% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $106M | $76M | $76M | $412M | $27M | |
| R&D Expense | · | · | $144M | $209M | $200M | |
| SG&A Expense | $62M | $62M | $70M | $73M | $43M | |
| Operating Expenses | $199M | $213M | $214M | $282M | $242M | |
| Operating Income | $-93M | $-137M | $-138M | $131M | $-216M | |
| Other Non-op | $51.0K | $-218.0K | $291.0K | $-42.0K | $118.0K | |
| Pretax Income | $-80M | $-117M | $-119M | $135M | $-212M | |
| Income Tax | $1M | $6M | $-568.0K | $11M | $-516.0K | |
| Net Income | $-81M | $-123M | $-119M | $124M | $-212M | |
| EPS (Basic) | $-1.08 | $-1.62 | $-1.72 | $1.91 | $-4.11 | |
| EPS (Diluted) | $-1.08 | $-1.62 | $-1.72 | $1.90 | $-4.61 | |
| Shares (Basic) | 75,404,897 | 75,846,681 | 68,863,010 | 65,194,775 | 51,553,869 | |
| Shares (Diluted) | 75,413,396 | 75,878,738 | 68,863,010 | 65,249,184 | 52,131,596 | |
| EBITDA | $-93M | $-137M | $-138M | · | · |
Bilanço 23
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $66M | $158M | $401M | $202M | |
| Short-term Investments | · | · | $217M | $91M | $51M | |
| Receivables | $5M | $56M | $19M | $33M | $16M | |
| Prepaid Expense | $15M | $19M | $19M | $19M | $20M | |
| Current Assets | $249M | $300M | $413M | $545M | $288M | |
| PP&E (Net) | $16M | $18M | $20M | $25M | $23M | |
| PP&E (Gross) | $36M | $35M | $41M | $38M | $37M | |
| Accum. Depreciation | $21M | $18M | $21M | $13M | $14M | |
| Goodwill | $12M | $12M | $12M | $12M | $12M | |
| Intangibles | $1M | $5M | $8M | $9M | $4M | |
| Total Assets | $347M | $463M | $581M | $649M | $389M | |
| Accounts Payable | $36M | $60M | $46M | $87M | $63M | |
| Current Liabilities | $42M | $88M | $56M | $96M | $72M | |
| Capital Leases | $15M | $16M | $22M | $25M | $31M | |
| Deferred Tax | $6M | $5M | $3M | $2M | $2M | |
| Other Non-current Liabilities | $278.0K | $923.0K | $2M | $3M | $3M | |
| Total Liabilities | $78M | $124M | $116M | $156M | $140M | |
| Common Stock | $1.11B | $1.02B | $997M | $886M | $741M | |
| Retained Earnings | $-953M | $-830M | $-677M | $-559M | $-683M | |
| AOCI | $-6M | $-7M | $-7M | $-7M | $-7M | |
| Stockholders' Equity | $269M | $339M | $465M | $493M | $249M | |
| Liabilities + Equity | $347M | $463M | $581M | $649M | $389M | |
| Shares Outstanding | 74,638,413 | 68,964,319 | 70,115,997 | 63,059,501 | 46,633,935 |
Nakit Akışı 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $28M | $18M | $8M | $4M | $11M | |
| Deferred Tax | $945.0K | $691.0K | $-757.0K | $2M | $-953.0K | |
| Amort. of Intangibles | $4M | $4M | $3M | $1M | $3M | |
| Restructuring | · | · | $0 | · | · | |
| Operating Cash Flow | $-33M | $-110M | $-118M | $144M | $-192M | |
| CapEx | $2M | $2M | $2M | $8M | $12M | |
| Investing Cash Flow | $27M | $39M | $-207M | $-54M | $145M | |
| Stock Issued | $0 | $0 | $26M | $108M | $0 | |
| Stock Repurchased | $42M | $30M | $0 | $0 | · | |
| Net Stock Activity | $-42M | $-30M | $26M | · | · | |
| Financing Cash Flow | $-19M | $-20M | $82M | $109M | $8M | |
| Net Change in Cash | $-25M | $-91M | $-243M | $199M | $-40M | |
| Taxes Paid | $1M | $3M | $165.0K | $10M | · | |
| Free Cash Flow | $-35M | $-112M | $-121M | · | · |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | -87.3% | -179.7% | -181.6% | · | · | |
| Net Margin | -76.6% | -160.8% | -156.1% | · | · | |
| Pretax Margin | -75.3% | -152.8% | -156.9% | · | · | |
| EBITDA Margin | -87.3% | -179.7% | -181.6% | · | · | |
| ROA | -20.0% | -23.5% | -19.3% | · | · | |
| ROE | -26.9% | -34.8% | -26.7% | · | · | |
| ROIC | -35.1% | -42.6% | -29.6% | · | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 3.4 | 7.4 | · | · | |
| Quick Ratio | 1.1 | 1.4 | 7.1 | · | · |
Verimlilik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.1 | 0.1 | · | · | |
| Receivables Turnover | 3.5 | 2.0 | 2.9 | · | · |
Büyüme Oranları 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | 38.9% | 0.38% | -81.6% | 1446.0% | -31.5% | |
| Revenue CAGR 3Y | -36.4% | 41.9% | 25.0% | · | · | |
| Revenue CAGR 5Y | 22.2% | · | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $106M | $76M | $76M | $412M | · | |
| Net Income TTM | $-81M | $-123M | $-119M | $124M | · | |
| Market Cap | $1.97B | $1.01B | $729M | · | · | |
| P/E | -24.4 | -9.0 | -6.0 | 4.1 | · | |
| P/S | 18.5 | 13.2 | 9.6 | · | · | |
| P/B | 7.3 | 3.0 | 1.6 | · | · | |
| P / Tangible Book | 7.7 | 3.1 | 1.6 | 1.0 | · | |
| P / Cash Flow | -59.5 | -9.2 | -6.2 | · | · | |
| P / FCF | -56.9 | -9.0 | -6.0 | · | · | |
| Earnings Yield | -4.1% | -11.1% | -16.6% | 24.2% | · |
Gelir Tablosu 14
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | $2M | $3M | $28M | $49M | $27M | $31M | $16M | $19M | $10M | $17M | $17M | $7M | $36M | $402M | $3M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | $32M | · | $33M | $39M | $46M | · | $37M | |
| SG&A Expense | $19M | $15M | $15M | $14M | $15M | $17M | $16M | $14M | $16M | $16M | $15M | $17M | $22M | $17M | $30M | $16M | |
| Operating Expenses | $47M | $50M | $47M | $50M | $49M | $53M | $53M | $50M | $62M | $48M | $40M | $50M | $61M | $63M | $83M | $53M | |
| Operating Income | $-42M | $-47M | $-44M | $-22M | $-674.0K | $-26M | $-22M | $-34M | $-43M | $-38M | $-23M | $-33M | $-54M | $-27M | $319M | $-50M | |
| Other Non-op | $196.0K | $120.0K | $-18.0K | $26.0K | $-621.0K | $49.0K | $-253.0K | $-37.0K | $53.0K | $19.0K | $-278.0K | $370.0K | $230.0K | $-31.0K | $-27.0K | $-98.0K | |
| Pretax Income | $-45M | $-46M | $-41M | $-18M | $2M | $-22M | $-18M | $-30M | $-38M | $-32M | $-19M | $-28M | $-49M | $-23M | $320M | $-48M | |
| Income Tax | $-273.0K | $-2M | $-270.0K | $1M | $-186.0K | $496.0K | $6M | $226.0K | $68.0K | $75.0K | $-5M | $1M | $2M | $1M | $11M | $-29.0K | |
| Net Income | $-45M | $-44M | $-41M | $-20M | $2M | $-23M | $-24M | $-30M | $-38M | $-32M | $-14M | $-29M | $-51M | $-24M | $309M | $-48M | |
| EPS (Basic) | $-0.62 | $-0.59 | $-0.55 | $-0.26 | $0.03 | $-0.30 | $-0.32 | $-0.39 | $-0.49 | $-0.42 | $-0.19 | $-0.41 | $-0.76 | $-0.36 | $4.78 | $-0.72 | |
| EPS (Diluted) | $-0.62 | $-0.59 | $-0.55 | $-0.26 | $0.03 | $-0.30 | $-0.32 | $-0.39 | $-0.49 | $-0.42 | $-0.18 | $-0.41 | $-0.76 | $-0.37 | $4.78 | $-0.72 | |
| Shares (Basic) | 72,993,313 | 74,668,790 | -150,871,069 | 75,767,778 | 75,337,168 | 75,171,020 | -152,889,276 | 76,128,531 | 76,392,593 | 76,214,833 | -135,733,099 | 70,575,773 | 67,281,028 | 66,739,308 | -129,002,888 | 66,477,016 | |
| Shares (Diluted) | 72,993,313 | 74,694,762 | -152,966,654 | 75,775,214 | 77,378,449 | 75,226,387 | -152,922,738 | 76,157,101 | 76,396,217 | 76,248,158 | -135,739,304 | 70,575,773 | 67,284,511 | 66,742,030 | -128,961,927 | 66,478,157 | |
| EBITDA | $-42M | $-47M | · | $-22M | $-674.0K | $-26M | · | $-34M | $-43M | $-38M | · | $-33M | $-54M | $-27M | · | $-50M |
Bilanço 23
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $179M | $244M | $41M | $65M | $98M | $76M | $66M | $122M | $71M | $115M | · | $94M | $142M | $182M | · | $96M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $201M | $198M | $159M | · | $70M | |
| Receivables | $6M | $5M | $5M | $29M | $3M | $25M | $56M | $24M | $32M | $31M | · | $67M | $49M | $67M | · | $7M | |
| Prepaid Expense | $22M | $16M | $15M | $10M | $12M | $17M | $19M | $23M | $21M | $18M | · | $12M | $31M | $19M | · | $18M | |
| Current Assets | $298M | $386M | $249M | $292M | $296M | $306M | $300M | $344M | $383M | $394M | · | $375M | $420M | $426M | · | $191M | |
| PP&E (Net) | $14M | $15M | $16M | $16M | $16M | $17M | $18M | $18M | $18M | $19M | · | $21M | $22M | $24M | · | $26M | |
| PP&E (Gross) | · | · | $36M | · | · | · | $35M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $21M | · | · | · | $18M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | · | $12M | $12M | $12M | · | $12M | |
| Intangibles | $998.0K | $1M | $1M | $1M | $2M | $3M | $5M | $6M | $7M | $7M | · | $8M | $7M | $8M | · | $9M | |
| Total Assets | $397M | $478M | $347M | $397M | $408M | $426M | $463M | $487M | $516M | $554M | · | $556M | $602M | $601M | · | $300M | |
| Accounts Payable | $27M | $30M | $36M | $34M | $31M | $38M | $60M | $52M | $44M | $47M | · | $68M | $70M | $59M | · | $52M | |
| Current Liabilities | $47M | $36M | $42M | $42M | $39M | $65M | $88M | $84M | $55M | $57M | · | $73M | $94M | $67M | · | $58M | |
| Capital Leases | $13M | $14M | $15M | $16M | $15M | $15M | $16M | $17M | $17M | $21M | · | $22M | $23M | $24M | · | $25M | |
| Deferred Tax | $4M | $4M | $6M | $5M | $5M | $5M | $5M | $3M | $3M | $3M | · | $2M | $2M | $2M | · | $2M | |
| Other Non-current Liabilities | $278.0K | $278.0K | $278.0K | $278.0K | $828.0K | $856.0K | $923.0K | $929.0K | $1M | $2M | · | $2M | $4M | $4M | · | $3M | |
| Total Liabilities | $317M | $315M | $78M | $77M | $74M | $101M | $124M | $120M | $109M | $116M | · | $132M | $153M | $127M | · | $121M | |
| Common Stock | $1.13B | $1.13B | $1.11B | $1.09B | $1.07B | $1.02B | $1.02B | $1.01B | $1.01B | $1.00B | · | $932M | $929M | $900M | · | $885M | |
| Retained Earnings | $-1.17B | $-1.07B | $-953M | $-886M | $-851M | $-853M | $-830M | $-798M | $-747M | $-709M | · | $-663M | $-634M | $-583M | · | $-868M | |
| AOCI | $-7M | $-7M | $-6M | $-6M | $-6M | $-6M | $-7M | $-6M | $-8M | $-8M | · | $-8M | $-8M | $-6M | · | $-7M | |
| Stockholders' Equity | $80M | $164M | $269M | $320M | $335M | $325M | $339M | $367M | $406M | $438M | $465M | $424M | $449M | $474M | $493M | $180M | |
| Liabilities + Equity | $397M | $478M | $347M | $397M | $408M | $426M | $463M | $487M | $516M | $554M | · | $556M | $602M | $601M | · | $300M | |
| Shares Outstanding | 71,412,072 | 73,102,689 | 74,638,413 | 75,139,281 | 74,846,147 | 69,584,811 | 68,964,319 | 69,584,882 | 70,831,545 | 70,677,106 | · | 67,922,559 | 67,687,384 | 64,083,770 | · | 61,694,387 |
Nakit Akışı 12
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $7M | $9M | $7M | $6M | $6M | $5M | $5M | $5M | $4M | $3M | $2M | $367.0K | $2M | $4M | $5M | |
| Amort. of Intangibles | $176.0K | $176.0K | $185.0K | $648.0K | $2M | $2M | $2M | $980.0K | $812.0K | $702.0K | $673.0K | $672.0K | $678.0K | $679.0K | $529.0K | $166.0K | |
| Operating Cash Flow | $-32M | $-46M | $-10M | $-31M | $12M | $-3M | $-42M | $-6M | $-25M | $-38M | $14M | $-43M | $-6M | $-83M | $327M | $-73M | |
| CapEx | $0 | $216.0K | $581.0K | $410.0K | $514.0K | $16.0K | $314.0K | $899.0K | $593.0K | $185.0K | $356.0K | $930.0K | $802.0K | $386.0K | $348.0K | $981.0K | |
| Investing Cash Flow | $17M | $70M | $5M | $368.0K | $9M | $12M | $-6M | $72M | $-20M | $-7M | $-1M | $-7M | $-61M | $-138M | $-22M | $-30M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | $26M | $0 | $0 | $0 | |
| Stock Repurchased | $52M | $76M | $25M | $16M | $0 | $0 | $9M | · | · | · | $0 | · | · | · | · | · | |
| Net Stock Activity | · | $-76M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-50M | $179M | $-19M | $-2M | $1M | $1M | $-9M | $-15M | $1M | $2M | $51M | $2M | $28M | $2M | $-377.0K | $628.0K | |
| Net Change in Cash | $-65M | $203M | $-24M | $-33M | $22M | $10M | $-56M | $51M | $-44M | $-43M | $63M | $-48M | $-39M | $-219M | $305M | $-103M | |
| Taxes Paid | $863.0K | $245.0K | $107.0K | $660.0K | $196.0K | $387.0K | $3M | $106.0K | $106.0K | $0 | · | · | · | · | · | · | |
| Free Cash Flow | · | $-46M | · | · | · | $-3M | · | · | · | $-38M | · | · | · | $-84M | · | · |
Kârlılık 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -919.0% | -1956.7% | · | -80.1% | -1.4% | -94.5% | · | -213.8% | -222.9% | -376.9% | · | -201.4% | -772.8% | -76.7% | · | -1914.0% | |
| Net Margin | -980.8% | -1834.0% | · | -71.0% | 4.8% | -83.5% | · | -186.6% | -195.8% | -315.6% | · | -173.8% | -730.5% | -68.5% | · | -1818.6% | |
| Pretax Margin | -986.8% | -1925.0% | · | -66.1% | 4.4% | -81.7% | · | -185.2% | -195.5% | -314.8% | · | -167.1% | -706.9% | -64.5% | · | -1819.7% | |
| EBITDA Margin | -919.0% | -1956.7% | · | -80.1% | -1.4% | -94.5% | · | -213.8% | -222.9% | -376.9% | · | -201.4% | -772.8% | -76.7% | · | -1914.0% | |
| ROA | -11.2% | -9.8% | · | -4.4% | 0.50% | -4.6% | · | -5.7% | -6.7% | -5.5% | · | -6.7% | -17.0% | -8.1% | · | -31.9% | |
| ROE | -21.7% | -18.1% | · | -5.7% | 0.63% | -5.9% | · | -7.5% | -8.8% | -6.9% | · | -9.5% | -22.8% | -10.3% | · | -53.2% | |
| ROIC | -52.2% | -27.4% | · | -7.4% | -0.22% | -8.1% | · | -9.4% | -10.6% | -8.6% | · | -8.2% | -12.5% | -6.1% | · | -28.0% |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.3 | 10.8 | · | 6.9 | 7.7 | 4.7 | · | 4.1 | 7.0 | 6.9 | · | 5.1 | 4.5 | 6.3 | · | 3.3 | |
| Quick Ratio | 3.9 | 7.0 | · | 2.2 | 2.6 | 1.5 | · | 1.7 | 1.9 | 2.6 | · | 5.0 | 4.2 | 6.1 | · | 3.0 |
Verimlilik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | |
| Receivables Turnover | 1.1 | 0.2 | · | 1.0 | 2.8 | 1.0 | · | 0.4 | 0.5 | 0.2 | · | 0.4 | 0.3 | 1.1 | · | 0.8 |
Değerleme (TTM) 10
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $83M | $106M | · | $119M | $111M | $72M | · | $62M | $53M | $69M | · | $62M | $51M | $46M | · | $14M | |
| Net Income TTM | $-106M | $-84M | · | $-70M | $-88M | $-122M | · | $-128M | $-149M | $-136M | · | $-152M | $-188M | $-209M | · | $-246M | |
| Market Cap | $1.87B | $1.83B | · | $1.28B | $939M | $829M | · | $873M | $603M | $744M | · | $431M | $585M | $579M | · | $379M | |
| P/E | -18.2 | -22.4 | · | -18.6 | -10.9 | -7.4 | · | -7.3 | -4.1 | -5.4 | · | -2.8 | -3.1 | -2.8 | · | -1.5 | |
| P/S | 22.4 | 17.3 | · | 10.7 | 8.5 | 11.4 | · | 14.1 | 11.4 | 10.8 | · | 7.0 | 11.5 | 12.7 | · | 26.4 | |
| P/B | 23.2 | 11.2 | · | 4.0 | 2.8 | 2.6 | · | 2.4 | 1.5 | 1.7 | · | 1.0 | 1.3 | 1.2 | · | 2.1 | |
| P / Tangible Book | 27.7 | 12.2 | · | 4.2 | 2.9 | 2.7 | · | 2.5 | 1.6 | 1.8 | · | 1.1 | 1.4 | 1.3 | · | 2.4 | |
| P / Cash Flow | · | -40.0 | · | · | · | -243.3 | · | · | · | -19.7 | · | · | · | -7.0 | · | · | |
| P / FCF | · | -39.9 | · | · | · | -242.1 | · | · | · | -19.6 | · | · | · | -6.9 | · | · | |
| Earnings Yield | -5.5% | -4.5% | · | -5.4% | -9.2% | -13.4% | · | -13.6% | -24.4% | -18.6% | · | -35.6% | -32.6% | -35.9% | · | -67.2% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $106M | $76M | $76M | $412M | $27M |
| Faaliyet Kâr Marjı % | -87.3% | -179.7% | -181.6% | — | — |
| Net Gelir | $-81M | $-123M | $-119M | $124M | $-212M |
| Seyreltilmiş Hisse Başı Kâr | $-1.08 | $-1.62 | $-1.72 | $1.90 | $-4.61 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 5.9 | 3.4 | 7.4 | — | — |
| Cari Oran | 1.1 | 1.4 | 7.1 | — | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-35M | $-112M | $-121M | — | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 218 dosya · $1.5B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 30 (-4 önceki Ç'ye göre) | 29 (-2 önceki Ç'ye göre) | 56 (-17 önceki Ç'ye göre) | 68 (+9 önceki Ç'ye göre) | +2.6M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| EcoR1 Capital, LLC | $600.445.942 | 22.970.388 | 39,27% | Hisse senetleri |
| Rubric Capital Management LP | $182.980.000 | 7.000.000 | 11,97% | Hisse senetleri |
| PERCEPTIVE ADVISORS LLC | $109.342.391 | 4.182.953 | 7,15% | Hisse senetleri |
| BVF INC/IL | $95.388.572 | 3.649.142 | 6,24% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $40.752.208 | 1.558.998 | 2,67% | Hisse senetleri |
| Assenagon Asset Management S.A. | $32.727.986 | 1.252.027 | 2,14% | Hisse senetleri |
| Nextech Invest Ltd. | $29.118.548 | 1.113.946 | 1,90% | Hisse senetleri |
| STATE STREET CORP | $28.445.966 | 1.088.216 | 1,86% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $24.486.776 | 936.755 | 1,60% | Hisse senetleri |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $23.259.000 | 889.802 | 1,52% | Hisse senetleri |
| CITADEL ADVISORS LLC | $21.330.894 | 816.025 | 1,40% | Hisse senetleri |
| FMR LLC | $18.355.822 | 702.212 | 1,20% | Hisse senetleri |
| Prosight Management, LP | $17.629.705 | 674.434 | 1,15% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $16.322.460 | 624.447 | 1,07% | Hisse senetleri |
| Nextech Invest Ltd. | $16.308.169 | 1.113.946 | 1,07% | Hisse senetleri |
| Qube Research & Technologies Ltd | $15.516.443 | 593.590 | 1,01% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13.332.236 | 510.032 | 0,87% | Hisse senetleri |
| Redmile Group, LLC | $12.851.836 | 491.654 | 0,84% | Hisse senetleri |
| Capricorn Fund Managers Ltd | $12.717.868 | 486.529 | 0,83% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $10.939.512 | 418.497 | 0,72% | Hisse senetleri |
| Hillsdale Investment Management Inc. | $10.009.581 | 382.922 | 0,65% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $9.345.338 | 357.511 | 0,61% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $8.897.088 | 340.363 | 0,58% | Hisse senetleri |
| Granahan Investment Management, LLC | $8.787.144 | 336.157 | 0,57% | Hisse senetleri |
| Pictet Asset Management Holding SA | $7.446.189 | 308.187 | 0,49% | Hisse senetleri |
| PICTON MAHONEY ASSET MANAGEMENT | $7.092.908 | 271.343 | 0,46% | Hisse senetleri |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $5.849.243 | 223.766 | 0,38% | Hisse senetleri |
| SummitTX Capital, L.P. | $5.510.364 | 210.802 | 0,36% | Hisse senetleri |
| Man Group plc | $5.509.763 | 210.779 | 0,36% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $5.182.437 | 198.257 | 0,34% | Hisse senetleri |
| STATE OF WISCONSIN INVESTMENT BOARD | $4.066.835 | 155.579 | 0,27% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.984.154 | 152.416 | 0,26% | Hisse senetleri |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $3.960.132 | 151.497 | 0,26% | Hisse senetleri |
| KENNEDY CAPITAL MANAGEMENT LLC | $3.800.390 | 145.386 | 0,25% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $3.785.255 | 144.807 | 0,25% | Hisse senetleri |
| DIADEMA PARTNERS LP | $3.715.330 | 142.132 | 0,24% | Hisse senetleri |
| BlackRock, Inc. | $3.614.744 | 138.284 | 0,24% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.408.656 | 130.400 | 0,22% | Alım opsiyonu |
| CITIGROUP INC | $3.364.872 | 128.725 | 0,22% | Hisse senetleri |
| XTX Topco Ltd | $3.290.425 | 125.877 | 0,22% | Hisse senetleri |
| PANAGORA ASSET MANAGEMENT INC | $3.100.282 | 118.603 | 0,20% | Hisse senetleri |
| PLATINUM INVESTMENT MANAGEMENT LTD | $2.749.510 | 105.184 | 0,18% | Hisse senetleri |
| AXA Investment Managers S.A. | $2.705.745 | 158.416 | 0,18% | Hisse senetleri |
| Manatuck Hill Partners, LLC | $2.614.000 | 100.000 | 0,17% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.451.932 | 93.800 | 0,16% | Satım opsiyonu |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $2.321.232 | 88.800 | 0,15% | Hisse senetleri |
| MACKENZIE FINANCIAL CORP | $2.293.654 | 87.745 | 0,15% | Hisse senetleri |
| VANGUARD GROUP INC | $2.251.979 | 85.529 | 0,15% | Hisse senetleri |
| Y-Intercept (Hong Kong) Ltd | $2.181.514 | 83.455 | 0,14% | Hisse senetleri |
| LMR Partners LLP | $2.156.550 | 82.500 | 0,14% | Hisse senetleri |
| PRINCIPAL FINANCIAL GROUP INC | $2.127.587 | 81.392 | 0,14% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $2.094.337 | 80.120 | 0,14% | Hisse senetleri |
| TEMA ETFS LLC | $2.000.422 | 75.975 | 0,13% | Hisse senetleri |
| RHUMBLINE ADVISERS | $1.962.211 | 75.066 | 0,13% | Hisse senetleri |
| Swiss National Bank | $1.939.588 | 74.200 | 0,13% | Hisse senetleri |
| MARTINGALE ASSET MANAGEMENT L P | $1.915.592 | 73.282 | 0,13% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $1.878.786 | 71.874 | 0,12% | Hisse senetleri |
| Dana Investment Advisors, Inc. | $1.873.192 | 71.660 | 0,12% | Hisse senetleri |
| CREDIT AGRICOLE S A | $1.855.940 | 71.000 | 0,12% | Hisse senetleri |
| Fisher Asset Management, LLC | $1.850.057 | 70.775 | 0,12% | Hisse senetleri |
| SEGALL BRYANT & HAMILL, LLC | $1.747.093 | 66.836 | 0,11% | Hisse senetleri |
| Verdad Advisers, LP | $1.743.224 | 66.688 | 0,11% | Hisse senetleri |
| Susquehanna Portfolio Strategies, LLC | $1.705.583 | 65.248 | 0,11% | Hisse senetleri |
| Campbell & CO Investment Adviser LLC | $1.591.246 | 60.874 | 0,10% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $1.399.636 | 55.896 | 0,09% | Hisse senetleri |
| CITADEL ADVISORS LLC | $1.364.508 | 52.200 | 0,09% | Alım opsiyonu |
| Virtus Investment Advisers, LLC | $1.328.566 | 50.825 | 0,09% | Hisse senetleri |
| ENVESTNET ASSET MANAGEMENT INC | $1.272.365 | 48.675 | 0,08% | Hisse senetleri |
| Quantinno Capital Management LP | $1.245.362 | 47.642 | 0,08% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $1.122.164 | 42.929 | 0,07% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $1.111.577 | 42.524 | 0,07% | Hisse senetleri |
| Bank of New York Mellon Corp | $1.076.785 | 41.193 | 0,07% | Hisse senetleri |
| MARSHALL WACE, LLP | $1.070.380 | 40.948 | 0,07% | Hisse senetleri |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $1.033.419 | 39.534 | 0,07% | Hisse senetleri |
| Aquilo Capital Management, LLC | $1.006.181 | 84.482 | 0,07% | Hisse senetleri |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $965.141 | 36.922 | 0,06% | Hisse senetleri |
| TUDOR INVESTMENT CORP ET AL | $953.352 | 36.471 | 0,06% | Hisse senetleri |
| HighTower Advisors, LLC | $943.654 | 36.100 | 0,06% | Hisse senetleri |
| Persistent Asset Partners Ltd | $939.341 | 35.935 | 0,06% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $936.221 | 37.389 | 0,06% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $904.653 | 34.608 | 0,06% | Hisse senetleri |
| HighVista Strategies LLC | $889.100 | 34.013 | 0,06% | Hisse senetleri |
| COMMONWEALTH EQUITY SERVICES, LLC | $837.838 | 32.052 | 0,05% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $827.157 | 31.415 | 0,05% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $807.360 | 30.886 | 0,05% | Hisse senetleri |
| SBI Okasan Asset Management Co.Ltd. | $771.200 | 32.000 | 0,05% | Hisse senetleri |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $735.529 | 27.935 | 0,05% | Hisse senetleri |
| MetLife Investment Management, LLC | $728.888 | 27.884 | 0,05% | Hisse senetleri |
| JOURNEY STRATEGIC WEALTH LLC | $722.304 | 28.846 | 0,05% | Hisse senetleri |
| STRS OHIO | $692.710 | 26.500 | 0,05% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $686.933 | 26.279 | 0,04% | Hisse senetleri |
| Brevan Howard Capital Management LP | $678.490 | 25.956 | 0,04% | Hisse senetleri |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $657.735 | 25.162 | 0,04% | Hisse senetleri |
| RITHOLTZ WEALTH MANAGEMENT | $633.712 | 24.243 | 0,04% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $607.206 | 23.229 | 0,04% | Hisse senetleri |
| Duncan Williams Asset Management, LLC | $577.563 | 22.095 | 0,04% | Hisse senetleri |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $564.049 | 21.578 | 0,04% | Hisse senetleri |
| BARCLAYS PLC | $524.577 | 20.068 | 0,03% | Hisse senetleri |
| SIMPLEX TRADING, LLC | $507.926 | 19.431 | 0,03% | Hisse senetleri |
| Invesco Ltd. | $491.720 | 18.811 | 0,03% | Hisse senetleri |
Şirket yöneticileri 28 içeriden öğrenenler · 12 yöneticiler · 17 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Kenneth Galbraith | Chair & CEO | 12 Ocak 2026 A | 226.842 | 0 | 4 | $-3.337.929 |
| Kristin Stafford | EVP, Chief Financial Officer | 06 Nisan 2026 A | — | 0 | 0 | $0 |
| Christopher Astle | SVP & Chief Financial Officer | 05 Ocak 2024 A | 6.503 | 0 | 0 | $0 |
| Neil A Klompas | President & COO | 10 Mart 2023 M | 17.032 | 0 | 0 | $0 |
| Mark Hollywood | EVP & Chief Operating Officer | 06 Temmuz 2026 A | 133.852 | 0 | 1 | $-138.740 |
| Paul R Schneider | EVP, General Counsel | 13 Mayıs 2026 A | — | 0 | 0 | $0 |
| Adam Schayowitz | EVP, Head of Research & Development | 09 Nisan 2026 A | — | 0 | 0 | $0 |
| Scott Platshon | EVP, Chief Business Officer | 09 Nisan 2026 A | — | 0 | 0 | $0 |
| Paul Andrew Moore | Chief Scientific Officer | 12 Ocak 2026 A | 48.497 | 0 | 3 | $-721.486 |
| Jeffrey T L Smith | EVP & Chief Medical Officer | 12 Ocak 2026 M | 26.708 | 0 | 2 | $-475.562 |
| Leone D Patterson | EVP, Chief Bus & Fin Officer | 06 Ocak 2026 A | 459 | 0 | 0 | $0 |
| Neil Josephson | Chief Medical Officer | 10 Kasım 2022 M | 14.449 | 0 | 0 | $0 |
| Gregory A. Ciongoli | Yönetim kurulu üyesi | 12 Ocak 2026 A | 488.500 | 0 | 0 | $0 |
| Alessandra Cesano | Yönetim kurulu üyesi | 12 Ocak 2026 A | — | 0 | 0 | $0 |
| Carlos Campoy | Yönetim kurulu üyesi | 12 Ocak 2026 A | — | 0 | 0 | $0 |
| Robert E Landry | Yönetim kurulu üyesi | 12 Ocak 2026 A | — | 0 | 0 | $0 |
| Kelvin Neu | Yönetim kurulu üyesi | 12 Ocak 2026 A | — | 0 | 0 | $0 |
| Susan Mahony | Yönetim kurulu üyesi | 12 Ocak 2026 A | — | 0 | 0 | $0 |
| Brian N Cherry | Yönetim kurulu üyesi | 12 Ocak 2026 A | — | 0 | 0 | $0 |
| EcoR1 Capital, LLC | Yönetim kurulu üyesi | 17 Ocak 2025 P | 15.720.161 | 0 | 0 | $0 |
| Nancy Davidson | Yönetim kurulu üyesi | 10 Aralık 2024 A | — | 0 | 0 | $0 |
| Neil Gallagher | Yönetim kurulu üyesi | 10 Aralık 2024 A | — | 0 | 0 | $0 |
| Derek John Michael Miller | Yönetim kurulu üyesi | 10 Aralık 2024 A | — | 0 | 0 | $0 |
| Troy Cox | Yönetim kurulu üyesi | 10 Aralık 2024 A | — | 0 | 0 | $0 |
| Kenneth J. Hillan | Yönetim kurulu üyesi | 07 Aralık 2023 A | — | 0 | 0 | $0 |
| Hollings Renton | Yönetim kurulu üyesi | 07 Aralık 2023 A | — | 0 | 0 | $0 |
| Natalie Sacks | Yönetim kurulu üyesi | 21 Aralık 2022 A | — | 0 | 0 | $0 |
| Lota S. Zoth | Yönetim kurulu üyesi | 21 Aralık 2022 A | — | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC, Oleg Nodelman, EcoR1 Capital Fund Qualified, L.P. ×8 başvurular | 19 Kasım 2025 | 30,70% | Değişiklik | Yönetim kurulu kampanyası | SEC |
| All Blue Falcons FZE, Daniel Edward Llewellen Cookson ×2 başvurular | 28 Aralık 2022 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 41 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| CANC · Tema ETF Trust | 1,51% | 105.615 NS | 31 Mayıs 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,80% | 10.832 NS | 30 Nisan 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,49% | 186.247 NS | 30 Nisan 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,25% | 110.902 NS | 30 Nisan 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,15% | 16.669 NS | 31 Mayıs 2026 | N-PORT |
| SMMV · iShares Trust | 0,13% | 16.160 SH | 08 Ağustos 2026 | Günlük |
| IBB · iShares Trust | 0,13% | 517.328 SH | 08 Ağustos 2026 | Günlük |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,12% | 14.789 SH | 08 Ağustos 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,12% | 3.975 SH | 08 Ağustos 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,10% | 74.514 SH | 08 Ağustos 2026 | Günlük |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,10% | 17.393 NS | 30 Nisan 2026 | N-PORT |
| BIB · ProShares Trust | 0,09% | 2.766 NS | 31 Mayıs 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,07% | 50.443 SH | 08 Ağustos 2026 | Günlük |
| IWO · iShares Trust | 0,07% | 423.822 SH | 08 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,06% | 67.771 SH | 08 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,04% | 21.639 NS | 30 Nisan 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 270.692 SH | 08 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,04% | 189.866 NS | 30 Nisan 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 1.183.337 SH | 08 Ağustos 2026 | Günlük |
| ITWO · ProShares Trust | 0,03% | 2.345 NS | 31 Mayıs 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 10.887 NS | 31 Mayıs 2026 | N-PORT |
| ISCV · iShares Trust | 0,02% | 5.753 SH | 08 Ağustos 2026 | Günlük |
| UWM · ProShares Trust | 0,02% | 1.834 NS | 31 Mayıs 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 16.794 NS | 30 Nisan 2026 | N-PORT |
| ISCB · iShares Trust | 0,02% | 1.999 SH | 08 Ağustos 2026 | Günlük |
| ISCG · iShares Trust | 0,01% | 5.891 SH | 08 Ağustos 2026 | Günlük |
| URTY · ProShares Trust | 0,01% | 1.855 NS | 31 Mayıs 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 3.008 SH | 08 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,01% | 110.298 SH | 08 Ağustos 2026 | Günlük |
| TILT · FlexShares Trust | 0,01% | 5.236 NS | 30 Nisan 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 1.925 NS | 31 Mayıs 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 26.839 NS | 31 Mayıs 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 47 NS | 31 Mayıs 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 5.213 NS | 30 Nisan 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 72.902 NS | 30 Nisan 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 12.951 NS | 30 Nisan 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 14.256 SH | 08 Ağustos 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,00% | 8.364 NS | 30 Nisan 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 130 NS | 30 Nisan 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.508.613 SH | 08 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.085 SH | 08 Ağustos 2026 | Günlük |